Abstract
Polycystic ovary syndrome (PCOS) is a complex disorder presenting reproductive and metabolic consequences. It has been associated with insulin resistance and hyperinsulinemia, which are responsible for the increase in metabolic risk and type II diabetes. However, it is estimated that 25-50% of PCOS patients do not present such abnormalities, demonstrating the heterogeneity of the syndrome…